Elixinol Global Share Price and Company Fundamentals
Last traded: Today at 6:10 AM
Elixinol Global Limited, through its subsidiaries, manufactures and distributes industrial hemp-based nutraceutical, dietary supplements, and skincare products in the Americas, Europe, and Australia. It distributes hemp-derived cannabidiol products under the Elixinol brand. The company was incorporated in 2017 and is headquartered in Sydney, Australia.
|Primary activities||Manufacture and distribution of industrial hemp products and early stage medical cannabis business focusing on the importation, cultivation, manufacture and distribution of CBD and THC products|
|Industry / Sector||Drug Manufacturers—Specialty & Generic / Healthcare|
|Mailing address||680 George Street Level 12 Sydney NSW 2000 Australia|
|Phone / Fax||61 2 4044 4585 / 61 2 4044 4585|
|Share registry||AUTOMIC REGISTRY SERVICES|
Elixinol Global paid $0.23 dividend and the ex-dividend date was .The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.EXL dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
EXL's forward dividend amount is $ and the forward dividend yield is . A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.
As of May 2021, following are the company executives and directors listed on Elixinol Global.
|Mr. Oliver Horn B.Sc.||Global CEO & Exec. Director||48||395.66k|
|Mr. Ron Dufficy BEC, FCPA||Global Chief Financial Officer||285k|
|Glen Zurcher||Account Director of Investor Relations Department|
|Ms. Teresa Cleary||Gen. Counsel & Company Sec.|
|Mr. Tom Siciliano||Chief Exec. Officer of Americas|
|Ms. Kim Bradley-Ware||Joint Company Sec.|
Profitability and management effectiveness
Return on assets
Return on equity
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Elixinol Global is 47.2M and its enterprise value is 21.89M. The enterprise value to revenue ratio of EXL is 1.46.
The EXL's stocks Beta value is 0.96 making it 4% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Elixinol Global (EXL)
Elixinol Global (ASX:EXL) Frequently Asked Questions
1. What is Elixinol Global's Stock Symbol?
Elixinol Global trades on ASX under the ticker symbol "EXL".
2. What is Elixinol Global's stock price today?
One share of EXL stock can currently be purchased for approximately $0.15.
3. How can I contact Elixinol Global?
Elixinol Global's mailing address is 680 George Street Level 12 Sydney NSW 2000 Australia. The company can be reached via phone at 61 2 4044 4585.
4. What is Elixinol Global's official website?
The official website of Elixinol Global is http://www.elixinolglobal.com.
5. Which share registry manages Elixinol Global's stock?
Elixinol Global's stock is managed by AUTOMIC REGISTRY SERVICES.